Zobrazeno 1 - 10
of 867
pro vyhledávání: '"Ming Lung Yu"'
Autor:
Mario Alvares da Silva, Fatima Higuera de la Tijera, Miguel Castruita Garcia, Oscar Beltran Galvis, Ming Lung Yu, Soo Aleman, Grace Lai-Hung Wong, Javier Garcia Samaniego, Joaquin Cabezas Gonzalez, Marta Casado Martin, Mohamed Alzaabi, Aastha Chandak, Marta Martinez, Artak Khachatryan, Linda Chen, Candido Hernandez Lopez, Yu Jun Wong
Publikováno v:
Annals of Hepatology, Vol 29, Iss , Pp 101625- (2024)
Conflict of interest: Yes, Gilead-sponsored research Introduction and Objectives: A previous real-world data (RWD) analysis demonstrated high effectiveness of sofosbuvir/velpatasvir (SOF/VEL) without ribavirin in > 6,000 HCV patients from 12 clinical
Externí odkaz:
https://doaj.org/article/898f05c648124c34ad7272abda27b210
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 40, Iss 11, Pp 962-971 (2024)
Abstract Universal neonatal hepatitis B virus (HBV) vaccination and the advent of direct‐acting antivirals (DAA) against hepatitis C virus (HCV) have reshaped the epidemiology of chronic liver diseases. However, some aspects of the management of ch
Externí odkaz:
https://doaj.org/article/d27f7333d42a4c2fbc4ecc66fdfcce63
Autor:
Chung-Feng Huang, Chia-Yen Dai, Yi-Hung Lin, Chih-Wen Wang, Tyng-Yuan Jang, Po-Cheng Liang, Tzu-Chun Lin, Pei-Chien Tsai, Yu-Ju Wei, Ming-Lun Yeh, Ming-Yen Hsieh, Chao-Kuan Huang, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 4, Pp 883-894 (2024)
Background/Aims Steatotic liver disease (SLD) is a common manifestation in chronic hepatitis C (CHC). Metabolic alterations in CHC are associated with metabolic dysfunction-associated steatotic liver disease (MASLD). We aimed to elucidate whether hep
Externí odkaz:
https://doaj.org/article/5db646915fc34d9b8352267c68373a63
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 4, Pp 1023-1025 (2024)
Externí odkaz:
https://doaj.org/article/efa82d2d0b9949559fb11e28d320ca2d
Autor:
Atish Mukherji, Frank Jühling, Yogy Simanjuntak, Emilie Crouchet, Fabio Del Zompo, Yuji Teraoka, Alexandre Haller, Philippe Baltzinger, Soumith Paritala, Fahmida Rasha, Naoto Fujiwara, Cloé Gadenne, Nevena Slovic, Marine A. Oudot, Sarah C. Durand, Clara Ponsolles, Catherine Schuster, Xiaodong Zhuang, Jacinta Holmes, Ming-Lun Yeh, Hiromi Abe-Chayama, Mathias Heikenwälder, Angelo Sangiovanni, Massimo Iavarone, Massimo Colombo, Steven K. H. Foung, Jane A. McKeating, Irwin Davidson, Ming-Lung Yu, Raymond T. Chung, Yujin Hoshida, Kazuaki Chayama, Joachim Lupberger, Thomas F. Baumert
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract Chronic liver disease and cancer are global health challenges. The role of the circadian clock as a regulator of liver physiology and disease is well established in rodents, however, the identity and epigenetic regulation of rhythmically exp
Externí odkaz:
https://doaj.org/article/faee0116ddb14568af297762b93cc7d2
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 3, Pp 326-344 (2024)
Hepatitis C virus (HCV) infection is one of the major etiologies of hepatocellular carcinoma (HCC) with approximately 30% of HCC being due to HCV infection worldwide. HCV eradication by antivirals greatly reduces the risk of HCC; nevertheless, HCC re
Externí odkaz:
https://doaj.org/article/7ed9c2fd992548d69c2e717a4f5b6fc7
Autor:
Pei-Chien Tsai, Chung-Feng Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, Hsing-Tao Kuo, Chao-Hung Hung, Kuo-Chih Tseng, Hsueh-Chou Lai, Cheng-Yuan Peng, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Chi‐Ming Tai, Chih-Wen Lin, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Chi-Yi Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chung, Ming-Jong Bair, Ming-Lung Yu, T-COACH Study Group
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 3, Pp 468-486 (2024)
Background/Aims Chronic hepatitis C (CHC) patients who failed antiviral therapy are at increased risk for hepatocellular carcinoma (HCC). This study assessed the potential role of metformin and statins, medications for diabetes mellitus (DM) and hype
Externí odkaz:
https://doaj.org/article/c4b167d9986a4d858ee7c5d56f112a9c
Autor:
Ming‐Lun Yeh, Chia‐Yen Dai, Chung‐Feng Huang, Shiu‐Feng Huang, Pei‐Chien Tsai, Po‐Yau Hsu, Ching‐I Huang, Yu‐Ju Wei, Po‐Cheng Liang, Ming‐Jong Bair, Mei‐Hsuan Lee, Zu‐Yau Lin, Jee‐Fu Huang, Ming‐Lung Yu, Wan‐Long Chuang
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 40, Iss 6, Pp 575-582 (2024)
Abstract Lifestyle modification is the standard of care for nonalcoholic fatty liver disease (NAFLD) patients. We aimed to investigate the efficacy of a short‐term lifestyle modification program in the disease course of Taiwanese nonalcoholic steat
Externí odkaz:
https://doaj.org/article/9836ab2271004d25a026d0f6ddf8f8fa
Autor:
Chih‐Wen Wang, Chung‐Feng Huang, Tyng‐Yuan Jang, Ming‐Lun Yeh, Po‐Cheng Liang, Yu‐Ju Wei, Po‐Yao Hsu, Ching‐I. Huang, Ming‐Yen Hsieh, Yi‐Hung Lin, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 40, Iss 5, Pp 477-488 (2024)
Abstract The immune response of patients with chronic liver disease tends to be lower after receiving their second coronavirus disease 2019 (COVID‐19) vaccine dose, but the effect of a third vaccine dose on their immune response is currently unknow
Externí odkaz:
https://doaj.org/article/9264613b93fd4a70ac8cddf8bfe3e0c6
Autor:
Chun-Chi Yang, Chung-Feng Huang, Te-Sheng Chang, Ching-Chu Lo, Chao-Hung Hung, Chien-Wei Huang, Lee-Won Chong, Pin-Nan Cheng, Ming-Lun Yeh, Cheng-Yuan Peng, Chien-Yu Cheng, Jee-Fu Huang, Ming-Jong Bair, Chih-Lang Lin, Chi-Chieh Yang, Szu-Jen Wang, Tsai-Yuan Hsieh, Tzong-Hsi Lee, Pei-Lun Lee, Wen-Chih Wu, Chih-Lin Lin, Wei-Wen Su, Sheng-Shun Yang, Chia-Chi Wang, Jui-Ting Hu, Lein-Ray Mo, Chun-Ting Chen, Yi-Hsiang Huang, Chun-Chao Chang, Chia-Sheng Huang, Guei-Ying Chen, Chien-Neng Kao, Chi-Ming Tai, Chun-Jen Liu, Mei-Hsuan Lee, Hsing-Tao Kuo, Pei-Chien Tsai, Chia-Yen Dai, Jia-Horng Kao, Han-Chieh Lin, Wang-Long Chuang, Kuo-Chih Tseng, Chi-Yi Chen, Ming-Lung Yu
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 6, Pp 1199-1213 (2024)
Abstract Introduction Eight-week glecaprevir/pibrentasvir (GLE/PIB) is indicated for treatment-naïve (TN) patients with chronic hepatitis C (CHC), with or without compensated cirrhosis. Given that the Taiwanese government is committed to eliminating
Externí odkaz:
https://doaj.org/article/14215fa1ee784d7ab2393d1356d5db36